| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.35 | 0.007 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.48 | 0.008 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |